News brief
On 2026-03-12, according to Xiniu Data, Phil Rivers completed Series A+ financing, raising RMB 200 million. Investors were Shengxiang Biotechnology, Shengweirongquan, Zhangjiangketou, Zhongkechuangxing.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年3月12日，据烯牛数据报道，哲源科技完成A+轮融资，金额2亿人民币。投资方为圣湘生物、圣维荣泉、张江科投、中科创星。